Anton Urusov is an expert in innovation and technological development with over 12 years of experience in venture capital and private equity. He is an alumnus of Moscow Institute of Physics and Technology (MIPT) and the Higher School of Economics, where he obtained his Master's degrees in Economics of Intellectual Property and Technology Entrepreneurship respectively, both with high GPAs. He also passed CFA Level I and completed an Executive MBA at HKUST Business School and Moscow School of Management SKOLKOVO. Urusov was the winner of the "Leaders of Russia" 2019 National Management Competition, showcasing his aptitude for leadership and management. Throughout his career, he has held various positions in different organizations, including Vice President at Russian Direct Investment Fund, Investment Director at JSC RUSNANO, and Engineer at Intel. He was also a member of an expert panel at Skolkovo Foundation and a permanent representative of the investor at BIOMARK CAPITAL FUND IV LP. Urusov's latest is playing an integral role in the global technology transfer and production of the Sputnik V vaccine with global CMO.